本页面由Tiger Trade Technology Pte. Ltd.提供服务

百济神州

351.21
-3.2600-0.92%
成交量:15.08万
成交额:5,303.99万
市值:400.38亿
市盈率:62.84
高:354.15
开:352.62
低:346.61
收:354.47
52周最高:385.22
52周最低:253.95
股本:1.14亿
流通股本:8,095.27万
量比:0.49
换手率:0.19%
股息:- -
股息率:- -
每股收益(TTM):5.59
每股收益(LYR):2.47
净资产收益率:14.66%
总资产收益率:7.46%
市净率:7.74
市盈率(LYR):142.19

数据加载中...

2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/14

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

关联方拟减持公告

Form 144 | BeOne Medicines Ltd. 高管 Xiaobin Wu 拟减持3991股,总价约151.83万美元
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities